Why is Fischer Medical falling/rising?

As of 10-Sep, Fischer Medical Ventures Ltd is experiencing a price increase, currently at 1,165.20, reflecting a rise of 29.9 or 2.63%. The stock has recently hit a new 52-week high and has been on a consecutive gain streak for the last eight days, accumulating an impressive 11.79% return during this period. Additionally, the company has shown strong performance over various time frames, with a year-to-date increase of 64.26% and a remarkable 1398.65% rise over the past three years. Positive factors contributing to this upward movement include a low debt-to-equity ratio, significant growth in net sales and profit, and consistent returns that have outperformed the BSE500 in the last three annual periods. However, concerns about poor management efficiency and low return on equity may temper investor enthusiasm.
In the broader market context, Fischer Medical's short-term performance has significantly outpaced the benchmark, with a 9.15% increase over the past week compared to the Sensex's 1.06% rise. This strong relative performance indicates that investor sentiment towards Fischer Medical is notably positive, especially given its recent financial results and consistent growth trajectory. Despite a decline in investor participation, as evidenced by a drop in delivery volume, the stock's liquidity remains sufficient for trading, suggesting that the current price movement is supported by underlying fundamentals rather than speculative trading.